Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD5024 1% cream vs metronidazole 0.75% cream in papulopustular rosacea
2011-004791-11Phase 3Completed
- Sponsor
- Galderma
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ivermectin in papulopustular rosacea (2 arms), sponsored by Galderma. Started Jan 2012; status: completed.
02
Drugs
ivermectin
03
Conditions
papulopustular rosacea
Beyond the preview
Go deeper on 2011-004791-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004791-11.